Skip to main content

Durect Corp

DRRXDelisted Sep 11, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001082038

Durect Corp was delisted on Sep 11, 2025; its insiders filed their last Form 4 on Sep 16, 2025; 40 institutions reported holding it in 13F filings for Q2 2025, worth $4.44M in total; no superinvestor held it.

Key figures

Market cap
–
Not available
Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
40
Q2 2025, +2 vs. previous quarter
13F value
$4.44M
Reported value at the end of Q2 2025
Superinvestors holding
0
At the end of Q2 2025

From SEC filings, in USD.

Revenue, FY2024
$2.03M
−76.2% year over year
Net income, FY2024
-$8.32M
No comparable prior period
Free cash flow, FY2024
-$19.1M
No comparable prior period
Revenue, Q2 FY2025
$447.0K
−79.4% year over year

Revenue flow, FY2024

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2024: $8.32M (409.8% of revenue).

Superinvestors holding DRRX, Q2 2025

Go to the superinvestors tab

No superinvestor reported holding DRRX at the end of Q2 2025.

Latest insider trades

See all insider trades

Open-market purchases and sales by Durect Corp insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 26, 2025 (view filing)Aug 224 daysAsen R Scott10% OwnerPPurchase+5.92K$1.92+$11.4K+0.2%2.67M after
Aug 22, 2025 (view filing)Aug 202 daysAsen R Scott10% OwnerPPurchase+87.6K$1.89+$165.6K+9.9%970.0K after
Aug 22, 2025 (view filing)Aug 211 dayAsen R Scott10% OwnerPPurchase+116.6K$1.90+$221.6K+4.6%2.67M after
Sep 11, 2024 (view filing)Dec 10, 20211,006 daysLateSussman NormanChief Medical OfficerSSale−9.00K$1.06−$9.54K−100.0%0 after
Aug 22, 2022 (view filing)Aug 18-194 daysRobertson Judith J.DirectorPPurchase+80.9K$0.85+$68.8K+29.4%356.1K after2 lots
Aug 19, 2022 (view filing)Aug 172 daysRobertson Judith J.DirectorPPurchase+10.2K$0.846+$8.62K+3.8%275.2K after2 lots
Aug 12, 2022 (view filing)Aug 12Same dayMaderis Gail JDirectorPPurchase+25.2K$0.71+$17.9K+14.4%200.0K after
Aug 11, 2022 (view filing)Aug 9-112 daysMaderis Gail JDirectorPPurchase+174.8K$0.6713+$117.3KNew position174.8K after3 lots
May 27, 2022 (view filing)5:31 PM ETMay 261 dayRobertson Judith J.DirectorPPurchase+65.0K$0.3938+$25.6K+32.5%265.0K after
May 25, 2022 (view filing)8:03 PM ETMay 241 dayAzab MohammadDirectorPPurchase+30.0K$0.3879+$11.6K+100.0%60.0K after5 lots

Top 10 13F holders, Q2 2025

See all 40 holders

The largest institutional positions in Durect Corp at the end of Q2 2025; share changes are against Q1 2025.

Institutions holding DRRX in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Richmond Brothers, Inc.1,453,735$923.4K0.60%+107,329+8.0%Added
Ingalls & Snyder LLC1,349,435$857.0K0.03%+14,637+1.1%Added
Vanguard Group Inc1,267,287$804.7K0.00%00.0%Unchanged
Dalton Investments LLC745,000$473.2K0.25%+232,688+45.4%Added
Gagnon Securities LLC403,884$256.5K0.05%00.0%Unchanged
Geode Capital Management, LLC330,268$209.8K0.00%−3,060−0.9%Reduced
Beirne Wealth Consulting Services, LLC314,150$199.5K0.06%+17,800+6.0%Added
BlackRock, Inc.280,818$178.4K0.00%00.0%Unchanged
Renaissance Technologies LLC177,766$112.9K0.00%+5,300+3.1%Added
Ironwood Investment Management LLC118,106$75.0K0.04%−45,828−28.0%Reduced

Holders of 5% or more of DRRX

See all 2 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Durect Corp.

Largest holders of DRRX from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Asen R Scott13G/A9.92%3.08M shares–Feb 16, 20243 filingsJan 8, 2025SEC
Ingalls & Snyder LLC13G/A8.50%2.68M shares–Mar 27, 20242 filingsFeb 21, 2025SEC